izpis_h1_title_alt

MicroRNA-target interaction regulatory network in Alzheimer’s disease
ID Turk, Aleksander (Avtor), ID Kunej, Tanja (Avtor), ID Peterlin, Borut (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,38 MB)
MD5: 5EA382DC4A110FE710F81E2FDCD5CA74
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2075-4426/11/12/1275 Povezava se odpre v novem oknu

Izvleček
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia; however, early diagnosis of the disease is challenging. Research suggests that biomarkers found in blood, such as microRNAs (miRNA), may be promising for AD diagnostics. Experimental data on miRNA–target interactions (MTI) associated with AD are scattered across databases and publications, thus making the identification of promising miRNA biomarkers for AD difficult. In response to this, a list of experimentally validated AD-associated MTIs was obtained from miRTarBase. Cytoscape was used to create a visual MTI network. STRING software was used for protein–protein interaction analysis and mirPath was used for pathway enrichment analysis. Several targets regulated by multiple miRNAs were identified, including: BACE1, APP, NCSTN, SP1, SIRT1, and PTEN. The miRNA with the highest numbers of interactions in the network were: miR-9, miR-16, miR-34a, miR-106a, miR-107, miR-125b, miR-146, and miR-181c. The analysis revealed seven subnetworks, representing disease modules which have a potential for further biomarker development. The obtained MTI network is not yet complete, and additional studies are needed for the comprehensive understanding of the AD-associated miRNA targetome.

Jezik:Angleški jezik
Ključne besede:Alzheimer’s disease, protein–protein interaction (PPI), biomarker, microRNA (miRNA), miRNA–target interaction (MTI)
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:BF - Biotehniška fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:18 str.
Številčenje:Vol. 11, iss. 12, art. 1275
PID:20.500.12556/RUL-133693 Povezava se odpre v novem oknu
UDK:616:575
ISSN pri članku:2075-4426
DOI:10.3390/jpm11121275 Povezava se odpre v novem oknu
COBISS.SI-ID:87716611 Povezava se odpre v novem oknu
Datum objave v RUL:09.12.2021
Število ogledov:720
Število prenosov:142
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Journal of personalized medicine
Skrajšan naslov:J. pers. med.
Založnik:MDPI
ISSN:2075-4426
COBISS.SI-ID:31207641 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:02.12.2021

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:medicina, Alzheimerjeva bolezen, bioinformatika, biomarkerji, genetika, miRNA, zunajcelični vezikli

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0326
Naslov:Ginekologija in reprodukcija: genomika za personalizirano medicino

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0220
Naslov:Primerjalna genomika in genomska biodiverziteta

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj